Acceptance of pharmaceutical gifts: Variability by specialty and job rank in a Saudi healthcare setting

Saudi Medical Journal

Volumn 34, Issue 8, 2013, Pages 854-860

  Alosaimi, Fahad ^a   AlKaabba, Abdulaziz ^c   Qadi, Mahdi ^d   Albahlal, Abdullah ^b   Alabdulkarim, Yasir ^b   Alabduljabbar, Mohammad ^b   Alqahtani, Faisal ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CROSS-SECTIONAL STUDY; GIFT GIVING; HEALTH CARE MANAGEMENT; HUMAN; JOB PERFORMANCE; OCCUPATIONAL PHYSICIAN; PERSONNEL MANAGEMENT; PHYSICIAN ATTITUDE; PHYSICIAN INCOME; SOCIOECONOMICS; STRUCTURED QUESTIONNAIRE;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDIES; DRUG INDUSTRY; ETHICS, MEDICAL; FEMALE; GIFT GIVING; HUMANS; MALE; MIDDLE AGED; PHYSICIANS; SAUDI ARABIA; YOUNG ADULT;

EID: 84888868521     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. The World Health Organization. Pharmaceutical Industry. Trade, foreign policy, diplomacy and health. (Accessed 2013 August 1). Available from URL: http://www.who.int/trade/ glossary/story073/en/index.html
2. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA; 283: 373-380.
3. Cain DM, Detsky AS. Everyone's a little bit biased (even physicians). JAMA 2008; 299: 2893-2895.
4. Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA 2006; 295: 429-433.
5. Grande D, Shea JA, Armstrong K. Pharmaceutical industry gifts to physicians: patient beliefs and trust in physicians and the health care system. J Gen Intern Med 2012; 27: 274-279.
6. Green MJ, Masters R, James B, Simmons B, Lehman E. Do gifts from the pharmaceutical industry affect trust in physicians? Fam Med 2012; 44: 325-331.
7. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med 2007; 356: 1742-1750.
8. Halperin EC, Hutchison P, Barrier RC Jr. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Int J Radiat Oncol Biol Phys 2004; 59: 1477-1483.
9. Saito S, Mukohara K, Bito S. Japanese practicing physicians' relationships with pharmaceutical representatives: a national survey. PLoS One 2010; 5: e12193.
10. McNeill PM, Kerridge IH, Henry DA, Stokes B, Hill SR, Newby D, et al. Giving and receiving of gifts between pharmaceutical companies and medical specialists in Australia. Intern Med J 2006; 36: 571-578.
11. Chimonas S, Rozario NM, Rothman DJ. Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws. Health Serv Res 2010; 45: 98-114.
12. Campbell EG, Rao SR, DesRoches CM, Iezzoni LI, Vogeli C, Bolcic-Jankovic D, et al. Physician professionalism and changes in physician-industry relationships from 2004 to 2009. Arch Intern Med 2010; 170: 1820-1826.
13. Lieb K, Brandtönies S. A survey of german physicians in private practice about contacts with pharmaceutical sales representatives. Dtsch Arztebl Int 2010; 107: 392-398.
14. Misra S, Ganzini L, Keepers G. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry. Acad Psychiatry 2010; 34: 102-108.
15. Castresana L, Mejia R, Aznar M. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry]. Medicina (B Aires). 2005; 65: 247-251.
16. Korenstein D, Keyhani S, Ross JS. Physician attitudes toward industry: a view across the specialties. Arch Surg 2010; 145: 570-577.
17. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110: 551-557.
18. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. JAMA 2003; 290: 252-5.
19. Pharmaceutical Research and Manufacturers of America. PhRMA code on interactions with healthcare professionals. (Updated: 2008 Accessed 2013 August 1). Available from URL: http:// www.natap.org/2008/HIV/PhRMAMarketingCode2008.pdf
20. Hollon MF. Direct-to-consumer marketing of prescription drugs: a current perspective for neurologists and psychiatrists. CNS Drugs 2004; 18: 69-77.
21. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. JAMA 1994; 271: 684-689.
22. Grande D. Limiting the influence of pharmaceutical industry gifts on physicians: self-regulation or government intervention? J Gen Intern Med 2010; 25: 79-83.
23. Gough IR, Dickinson I, Maddern G, Grigg M, Hillis DJ. Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry. Med J Aust 2010; 192: 293-294.